text,labels
Normal-weight subjects showed significant blood oxygen level-dependent responses in the ventromedial prefrontal cortex ( vmPFC ) to food aromas compared with responses induced by the odor of an inedible object .,3
Female : 35.6 % .,3
"PrEP is efficacious for HIV-1 prevention among women using DMPA and men whose partners use DMPA , suggesting PrEP could mitigate the potential increased HIV-1 acquisition and transmission risks that have been associated with DMPA use .",4
"The SSM 30 g may be an effective , noninvasive alternative to health care provider-administered intravenous , intramuscular , or oral opioids for the management of moderate-to-severe acute pain .",4
"When compared to the odor of an inedible object, food aromas resulted in significant blood oxygen level-dependent responses in the ventromedial prefrontal cortex (vmPFC) in normal-weight subjects.",3
"The ventromedial prefrontal cortex (vmPFC) of normal-weight individuals exhibited noteworthy blood oxygen level-dependent responses to food aromas, in contrast to the responses elicited by the odor of an inedible object.",3
"Significant blood oxygen level-dependent responses were observed in the ventromedial prefrontal cortex (vmPFC) of normal-weight subjects in response to food aromas, whereas the odor of an inedible object generated different responses.",3
"In normal-weight participants, the ventromedial prefrontal cortex (vmPFC) displayed significant blood oxygen level-dependent responses when exposed to food aromas, as opposed to the responses evoked by the odor of an inedible object.",3
"Comparatively, normal-weight subjects exhibited notable blood oxygen level-dependent responses in the ventromedial prefrontal cortex (vmPFC) upon exposure to food aromas, in contrast to the responses elicited by the scent of an inedible object.",3
"The response of the ventromedial prefrontal cortex (vmPFC) to food aromas was significantly different in normal-weight subjects, as indicated by their blood oxygen level-dependent responses, in comparison to the responses evoked by the odor of an inedible object.",3
The female population accounts for 35.6 percent.,3
"Out of the total, 35.6 percent are women.",3
Women make up 35.6 percent of the demographic.,3
35.6 percent of the population is female.,3
The proportion of females is 35.6 percent.,3
Females represent 35.6 percent of the total.,3
"DMPA users, both men whose partners use it and women using it, can benefit from the efficacy of PrEP in preventing HIV-1, thus reducing the potential risks associated with DMPA use.",4
"The effectiveness of PrEP in HIV-1 prevention extends to women using DMPA and men whose partners use DMPA, offering a means to mitigate the heightened risks of HIV-1 acquisition and transmission linked with DMPA usage.",4
"By utilizing PrEP, individuals using DMPA, both women and men with partners who use it, can reduce the risks associated with HIV-1 acquisition and transmission, thus emphasizing its efficacy for prevention.",4
"PrEP demonstrates its efficacy in HIV-1 prevention among women using DMPA and men whose partners also use DMPA, which implies a potential solution for mitigating the heightened risks associated with DMPA usage.",4
"The use of PrEP proves to be effective in preventing HIV-1 among DMPA users, both women and men with partners using DMPA, suggesting its potential in reducing the risks associated with DMPA usage.",4
"Women using DMPA and men whose partners use it can benefit from the efficacy of PrEP in preventing HIV-1, highlighting the possibility of minimizing the increased risks of HIV-1 acquisition and transmission related to DMPA use.",4
"Managing moderate-to-severe acute pain might be possible with the SSM 30 g, an efficient and noninvasive option that replaces the need for healthcare providers to administer opioids intravenously, intramuscularly, or orally.",4
"For individuals dealing with moderate-to-severe acute pain, the SSM 30 g offers a potential solution that avoids the need for healthcare providers to administer opioids through invasive methods such as intravenous, intramuscular, or oral means.",4
"When it comes to effectively managing moderate-to-severe acute pain, healthcare providers can opt for the SSM 30 g as an alternative that circumvents the necessity of administering opioids intravenously, intramuscularly, or orally.",4
"The SSM 30 g presents itself as a viable option for the management of moderate-to-severe acute pain, providing a noninvasive alternative to healthcare provider-administered opioids through intravenous, intramuscular, or oral routes.",4
"Seeking relief from moderate-to-severe acute pain? Consider the SSM 30 g, an effective alternative that eliminates the need for healthcare providers to resort to opioids administered intravenously, intramuscularly, or orally.",4
"Opting for the SSM 30 g can prove beneficial in managing moderate-to-severe acute pain, bypassing the requirement for healthcare providers to use invasive methods like intravenous, intramuscular, or oral opioids.",4
